{"cord_uid": "vgfdfuza", "sourcedb": "PMC", "sourceid": "PMC6963657", "divid": "53", "text": "Participants articulated that highlighting the increasing cost of managing patients infected with resistant organisms and the economic loss from AMR could be a potential way of drawing attention to the topic and getting funds to drive programs . As specific examples , participants illustrated not just the costs of treating resistant infections , but also the costs associated with implementing stricter infection control measures .", "project": "cdlai_CORD-19", "denotations": [{"id": "A-biobert_T1", "span": {"begin": 145, "end": 149}, "obj": "Disease"}]}